ArticleFrontiers in pharmacology2023

A phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy Chinese subjects.

Qian Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.